Work

Long-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image-Guided Intensity-Modulated Radiotherapy for Localized High-Risk Prostate Adenocarcinoma

Year: 2021

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2021.07.912

Authors: S.M. McVorran, D.T. Marshall

Institution: MUSC Hollings Cancer Center

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Boston Scientific Corporation, NRG Oncology, National Cancer Institute

OpenAlex ID: W3208995796

FWCI:

Cites:

Cited by:

Related to: 10